Details
Stereochemistry | ACHIRAL |
Molecular Formula | C28H32FN5O4 |
Molecular Weight | 521.5832 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(=O)N1CCN(CC1)C2=CC=C(NC(=O)C3=CC(=O)C4=CC(F)=CC(N5CCN(C)CC5)=C4O3)C=C2
InChI
InChIKey=CKBARMWSFIJZTL-UHFFFAOYSA-N
InChI=1S/C28H32FN5O4/c1-3-26(36)34-14-12-32(13-15-34)21-6-4-20(5-7-21)30-28(37)25-18-24(35)22-16-19(29)17-23(27(22)38-25)33-10-8-31(2)9-11-33/h4-7,16-18H,3,8-15H2,1-2H3,(H,30,37)
Molecular Formula | C28H32FN5O4 |
Molecular Weight | 521.5832 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:32:49 GMT 2023
by
admin
on
Sat Dec 16 11:32:49 GMT 2023
|
Record UNII |
GR7FP8T3TF
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
GR7FP8T3TF
Created by
admin on Sat Dec 16 11:32:49 GMT 2023 , Edited by admin on Sat Dec 16 11:32:49 GMT 2023
|
PRIMARY | |||
|
AZD-1134
Created by
admin on Sat Dec 16 11:32:49 GMT 2023 , Edited by admin on Sat Dec 16 11:32:49 GMT 2023
|
PRIMARY | Biological descriptionFluorescent 5-HT1B antagonist (pKD = 6.71). No intrinsic agonist activity in vitro. Wide range of applications which include localizing receptor distribution in tissues and cells, and live-cell imaging of receptor kinetics. | ||
|
442548-99-4
Created by
admin on Sat Dec 16 11:32:49 GMT 2023 , Edited by admin on Sat Dec 16 11:32:49 GMT 2023
|
PRIMARY | |||
|
9830790
Created by
admin on Sat Dec 16 11:32:49 GMT 2023 , Edited by admin on Sat Dec 16 11:32:49 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Class: Antidepressant, Anxiolytic: Mechanism of Action: Serotonin 1B receptor antagonist; Highest Development Phase: Discontinued for Anxiety disorders and Major depressive disorder; Most Recent Events: 31 Mar 2004 Discontinued - Preclinical for Depression in USA (unspecified route), 31 Mar 2004 Discontinued - Preclinical for Anxiety disorders in USA (unspecified route)
|